Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." The post Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues appeared first on Investor's Business Daily.
Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024."
The post Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues appeared first on Investor's Business Daily.